logo

BOLT

Bolt Biotherapeutics·NASDAQ
--
--(--)
--
--(--)

BOLT fundamentals

Bolt Biotherapeutics (BOLT) released its earnings on Aug 14, 2025: revenue was 1.80M (YoY +41.18%), beat estimates; EPS was -4.46 (YoY +60.18%), beat estimates.
Revenue / YoY
1.80M
+41.18%
EPS / YoY
-4.46
+60.18%
Report date
Aug 14, 2025
Earnings Call
7:00 AM on Aug 14, 2025
Meeting link.
EPS
Q4,2020
Q1,2021
Q2,2021
Q3,2021
Q4,2021
Q1,2022
Q2,2022
Q3,2022
Q4,2022
Q1,2023
Q2,2023
Q3,2023
Q4,2023
Q1,2024
Q2,2024
Q3,2024
Q4,2024
Q1,2025
Q2,2025
Actual
-291.4-21.8-12.8-12.6-14.6-12.8-12.2-11.6-10.6-9-9.6-8.6-9.4-5.6-11.2-8-8.4-5.8-4.46
Forecast
-12.8667-13.65-11.7-15-16.16-14.05-13.15-11.0667-11.7333-10-9.5333-10-9.4-10.2-8.76-6.8-7.6-7.1-6.3
Surprise
-2164.76%
-59.71%
-9.40%
+16.00%
+9.65%
+8.90%
+7.22%
-4.82%
+9.66%
+10.00%
-0.70%
+14.00%
0.00%
+45.10%
-27.85%
-17.65%
-10.53%
+18.31%
+29.21%
Revenue
Q4,2020
Q1,2021
Q2,2021
Q3,2021
Q4,2021
Q1,2022
Q2,2022
Q3,2022
Q4,2022
Q1,2023
Q2,2023
Q3,2023
Q4,2023
Q1,2024
Q2,2024
Q3,2024
Q4,2024
Q1,2025
Q2,2025
Actual
000752.00K508.00K813.00K1.39M2.11M1.41M1.83M1.43M2.53M2.09M5.27M1.27M1.14M10.00K1.22M1.80M
Forecast
33.33K03.33M375.00K375.00K500.00K500.00K990.00K1.24M1.54M1.91M1.73M1.71M2.08M1.01M1.25M775.67K757.25K819.75K
Surprise
-100.00%
0.00%
-100.00%
+100.53%
+35.47%
+62.60%
+178.60%
+113.33%
+14.25%
+18.57%
-25.00%
+46.47%
+21.96%
+154.17%
+26.82%
-8.76%
-98.71%
+61.37%
+119.58%

Earnings Call